MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - INDOCO REMEDIES

Indoco Remedies

BSE: 532612 | NSE: INDOCO | ISIN: INE873D01024 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 17, 17:00
65.15
0.05 (+0.08%)
VOLUME 16,001
AVERAGE VOLUME
5-Day 12,424
10-Day 9,074
30-Day 8,606
VOLUME SHOCKER
5-Day 12,424
10-Day 9,074
30-Day 8,606
Prev. Close
65.10
Open Price
64.50
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 63.00 65.60
52 Wk Low/High 51.40 83.00
LIVE
NSE
May 17, 17:00
65.10
0.15 (+0.23%)
VOLUME 18,044
AVERAGE VOLUME
5-Day 36,564
10-Day 29,072
30-Day 23,071
VOLUME SHOCKER
5-Day 36,564
10-Day 29,072
30-Day 23,071
Prev. Close
64.95
Open Price
64.00
Bid PRICE (QTY.)
65.10 (57)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 63.05 65.50
52 Wk Low/High 51.70 75.40
MARKET CAP (Rs Cr)
600.36
*P/E
14.19
*BOOK VALUE (Rs)
38.00
DIV (%)
82.50%
Market Lot
1
INDUSTRY P/E
28.46
*EPS (TTM)
4.59
*P/C
9.75
*PRICE/BOOK
1.71
DIV YIELD.(%)
2.53%
FACE VALUE (Rs)
2.00
DELIVERABLES (%)
61.89 new
DELIVERY AVERAGES
3-Day 74.15%
5-Day 77.85%
8-Day 77.00%
* Based on standalone numbers
Track Indoco Remedies on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 28-May-2013 (Audited Results & Final Dividend)
EXPAND ALL COLLAPSE ALL
Would you bet on Indoco Remedies today?
Test your strategy with virtual money on Moneybhai
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 61.80 64.50  
High Price 66.00 65.60  
Low Price 57.15 63.00  
Last Price 58.25 65.15 11.85
Volume 52,867 16,001 -69.73
Simple Moving Averages
Days BSE NSE
30 62.61 62.56
50 62.42 62.44
150 63.77 63.80
200 64.07 64.11

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Indoco Remedies

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Dec '12)
Quarterly
(Mar '12)
Yearly
Net Sales 153.31 568.77
Other Income 0.42 2.25
PBDIT 19.66 86.83
Net Profit 7.38 46.34

Annual Report

Download in PDF format 2012 |2010
Balance Sheet
(Mar '12)
(In Rs Cr)
Total Share Capital 12.29
Net Worth 384.76
Total Debt 114.16
Net Block 317.35
Investments 0.12
Net Current Assets 157.83
Total Assets 498.93
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 965.30 -0.33 997.95 569.00 99,964.73
Lupin 804.25 -0.33 810.80 519.00 36,001.21
Dr Reddys Labs 2077.65 -1.80 2150.90 1555.00 35,286.08
Cipla 424.65 0.57 435.00 305.00 34,096.06
Ranbaxy Labs 471.45 -0.77 578.30 370.50 19,947.10
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Dec' 12Sep' 12Mar' 12Dec' 11
Promoter59.1959.1959.1961.06
FII1.631.991.662.75
DII14.0714.1314.9814.12
Others25.1124.6924.1722.07
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Indoco House, 166 CST Road,,Kalina,
City
Mumbai
State
Maharashtra
Pin Code
400098
Tel. No.
022-26541851
Fax No.
022-26520787
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-13, Pannalal Silk Mill Compound, LBS Marg, Bhandup (West)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25960320
Fax No.
022-25960329
MANAGEMENT
Name
Designation
Suresh G Kare
Executive Chairman
Aditi Panandikar
Managing Director
Sundeep V Bambolkar
Joint Managing Director
D M Gavaskar
Director
Rajiv P Kakodkar
Director
Message Board & Community
Quick Links for Indoco Remedies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.